Persistent Fetal SVT in a COVID-19 Positive Pregnancy

Division

Mid America

Hospital

Menorah Medical Center

Document Type

Case Report

Publication Date

1-7-2022

Keywords

sars-cov-2, coronavirus infections, COVID-19, upraventricular tachycardia

Disciplines

Cardiovascular Diseases | Female Urogenital Diseases and Pregnancy Complications | Obstetrics and Gynecology | Virus Diseases

Abstract

Background: Rapid introduction and spread of SARS-CoV-2 have posed unique challenges in understanding the disease, role in vertical transmission, and in developing management. We present a case of a patient with COVID-19 infection and fetus with new-onset fetal SVT.

Case: A 26-year-old gravida 4 para 2012 with third trimester COVID-19 infection was diagnosed with new onset fetal SVT. Successful cardioversion was achieved with flecainide. The patient was followed outpatient until induction of labor at 39 and 3/7 weeks of gestational age resulting in an uncomplicated vaginal delivery. Postpartum course was uncomplicated.

Conclusion: Fetal SVT is a potential complication of maternal COVID-19 infection. The use of transplacental therapy with flecainide is an appropriate alternative to digoxin in these cases.

Publisher or Conference

Case Reports in Obstetrics and Gynecology

Link to Full Text

Share

COinS